GenWorks Health, a medical device distributor in Tier II/III India, has raised Rs 15 crore from Blacksoil. According to a statement by the company, the funds will be used for meeting the working capital requirements and expanding the company’s newly acquired In-Vitro Diagnostics segment of IRIS Healthcare. The acquisition complements and accelerates the current In-Vitro Diagnostics segment of Health and improves its geographical footprint, reported YourStory.
“We are pleased to tie up with Blacksoil and have them as our partner, their funding is a strong boost to our expansion activities and will help us grow our product portfolio as we continue to onboard various segments to build our care cycle,” S Ganeshprasad, co-founder, MD, and CEO of GenWorks Health said.
GenWorks Health started in 2015 as a medical device distributor for GE Wipro and has expanded its product portfolio to cover almost everything in the care cycle, starting from screening and diagnosis to treatment and monitoring.
Also, Read This: Manipal Hospitals Announces 100 percent Acquisition In Vikram Hospital
Apart from the distribution of medical equipment, the startup also provides software solutions and interpretation services as well as related maintenance, repair, and installation services in the area of maternal and infant care, women’s health, cardiology, oncology, in-vitro diagnostics, radiology, surgery, and critical care.
“GenWorks Health has created a strong distribution network across India and has tie-ups for best in class medical device manufacturers in the country. Their robust portfolio of products covers most areas required in a ‘care cycle’. COVID has also heightened the need for quality healthcare across the country. We are pleased to be associated with the company and are glad we can play a role in helping the improvement of the healthcare system of India,” added Ankur Bansal, director, Blacksoil Capital.
